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Leptospirosis is a zoonosis caused by pathogenic bacteria from the genus Leptospira.The
disease represents a serious public health problem in underdeveloped tropical countries.
Leptospires infect hosts through small abrasions in the skin or mucous membranes and
they rapidly disseminate to target organs. The capacity of some pathogenic leptospiral
strains to acquire the negative complement regulators factor H (FH) and C4b binding pro-
tein correlates with their ability to survive in human serum. In this study we assessed the
functional consequences of the age macular degeneration-associated polymorphism FH
His402 or FH Tyr402 on FH–Leptospira interactions. In binding assays using sub-saturating
amounts of FH, the FH Tyr402 variant interacted with all the strains tested more strongly
than the FH His402 variant. At higher concentrations, differences tended to disappear. We
then compared cofactor activities displayed by FHHis402 and FHTyr402 bound to the surface
of L. interrogans. Both variants exhibit similar activity as cofactors for Factor I-mediated
cleavage of C3b, thus indicating that they do not differ in their capacity to regulate the
complement cascade.
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INTRODUCTION
Leptospirosis is a serious public health problem in tropical devel-
oping countries. The disease is transmitted by spirochetes of the
genus Leptospira, directly or indirectly from animals to humans in
regionswhich lack adequate sewage systems. PathogenicLeptospira
enter the body, reach the bloodstream and can potentially invade
potentially all tissues and organs (Faine et al., 1999). Clinical
manifestations are quite variable and can range from an asympto-
matic, subclinical infection to a fatal hepatorenal syndrome (Weil’s
disease), severe pulmonary form, including pulmonary hemor-
rhage and acute respiratory distress syndrome, fever and jaundice
(Faine et al., 1999; Levett, 2001; Bharti et al., 2003), and uveitis
(Pappachan et al., 2007).
Prompted by the necessity of developing an efﬁcient subunit
vaccine against human leptospirosis, considerable research is being
conducted to understand the mechanisms and putative virulence
factors that enable pathogenic Leptospira to disseminate through-
out the host, culminating in the colonization of multiple organs.
Of particular interest are mechanisms that allow Leptospira to
evade innate immune system, notably clearance mediated by the
alternative pathway (AP) of complement. Leptospira strains dif-
fer in resistance to complement-mediated lysis, and the ability
to survive in human serum correlates with the capacity of some
pathogenic strains to acquire the negative complement regulators
factor H (FH) and C4b binding protein (C4BP) on their surfaces
(Meri et al., 2005; Barbosa et al., 2009).
Complement FH, a 155-kDa plasma glycoprotein composed of
20 globular domains (termed short consensus repeats, SCRs), is
the major soluble complement regulator that controls AP activa-
tion and the ampliﬁcation reaction at the C3 level. It inhibits the
complement AP by preventing binding of Factor B to C3b, accel-
erating decay of the C3-convertase C3bBb and acting as a cofactor
for the cleavage of C3b by Factor I (Weiler et al., 1976; Whaley
and Ruddy, 1976; Pangburn et al., 1977). FH, encoded by the HF1
gene, is as a single chain with 1231 amino acid residues. The regu-
latory function on complement ampliﬁcation is conferred by the
ﬁrst four domains (Gordon et al., 1995; Kühn and Zipfel, 1996),
while the remaining 16 SCRs present several binding sites for
different targets, including: self surfaces, thereby preventing com-
plement activation on host cells (Sharma and Pangburn, 1996);
C3 fragments (Zipfel et al., 1999); C-Reactive Protein (Mold et al.,
1999; Ormsby et al., 2006); ﬁbromodulin (Sjöberg et al., 2005);
adrenomedullin (Pio et al., 2001); cell receptors (Jarva et al., 1999;
Zipfel et al., 2002);M protein and heparin (Sharma and Pangburn,
1997; Giannakis et al., 2003).
The polymorphism (Tyr402His) located in SCR7 of both FH
and factor H-like protein 1 (FHL-1) has been associated with age
macular degeneration (AMD) by different groups (Edwards et al.,
2005; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005;
Teixeira et al., 2010). The frequency of the His402 allotype of FH
in the population is quite relevant. Approximately 35% of Euro-
pean descendants carry this allele (Clark et al., 2010). In Brazilian
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subjects (a highly ethnically mixed population) the frequency of
this allele is 13% (Teixeira et al., 2010). Additionally, this same FH
polymorphism was associated with other chronic diseases, such as
Alzheimer disease (Zetterberg et al., 2008).
The hypothesis that this FH polymorphism could affect FH
binding properties was approached by several groups (Laine et al.,
2007; Skerka et al., 2007; Yu et al., 2007; Haapasalo et al., 2008) in
studies that evaluated the effect of the Tyr402His substitution on
binding of FH to heparin, C-reactive protein, and bacterial sur-
face proteins. Using SCR 5–7 domains from FH His402 variant,
Laine et al. (2007) observed a weaker binding to C-reactive pro-
tein when compared to SCR 5–7 from FH Tyr402. They obtained
similar results when puriﬁed human FH variants were employed.
In addition,no differences in the binding to heparinwere observed
(Laine et al., 2007). On the other hand, the binding of the Tyr402
and His402 allotype to C-reactive protein did not differ in a study
reported byYu et al. (2007). However, this group observed that the
Tyr402 allotype binds much better to M6 protein from Streptococ-
cus pyogenes. A study by Haapasalo et al. (2008) demonstrated that
the FH Tyr402 and FH His402 allotypes display different binding
afﬁnities for several group A Streptococcus (GAS) strains: binding
of the FH His402 allotype to GAS is signiﬁcantly weaker compared
to that exhibited by the FH Tyr402 allotype. As a consequence,
GAS strains are more susceptible to phagocytosis in the presence
of theHis402 allele due to increasedC3bdeposition on the bacterial
surface (Haapasalo et al., 2008).
Given the small number of investigations assessing the func-
tional consequences of the age-related macular degeneration-
associated polymorphismTyr402His on FH–pathogen interactions
and the fact that leptospires may cause eye diseases such as uveitis,
the main purpose of the present study was to compare binding of
Tyr402 and His402 FH variants to pathogenic Leptospira strains.We
also evaluated cofactor activity displayed by both variants bound
to the leptospiral surface in order to assess if they differ in their
capacity to regulate the complement cascade.
MATERIALS AND METHODS
PURIFICATION OF FH (His402) AND FH (Tyr402) VARIANTS
The two allotypes were isolated from 100ml EDTA plasma col-
lected from homozygous healthy donors after previous genotyp-
ing, according to Teixeira et al. (2010). Brieﬂy, the material was
treated with 10mM CaCl2 and 0.6mM phenylmethylsulfonyl ﬂu-
oride (ﬁnal concentrations) in order to block the protease cascade,
followed by dialysis in 8mM EDTA and 10mM benzamidine,
pH 5.8, for 18 h at 4˚C. The precipitate was washed twice in
the same solution and solubilized in 10mM Tris–HCl, 150mM
NaCl,100mMdextrose, 100mMglycine, and 0.01% sodiumazide,
pH 8.5. The material was then separated by gel ﬁltration chro-
matography using a Sephacryl S-200 column (GE Healthcare Life
Sciences). The fractions containing FH were pooled and dia-
lyzed against 40mM NaH2PO4 pH 8.1 overnight and loaded in
Sepharose 4B-CNBr activated resin (GE Healthcare Life Sciences)
containing polyclonal anti-human FH antibodies (Calbiochem).
FH was eluted with 100mM glycine, pH 2.7. The fractions con-
taining FH were pooled, concentrated, and re-puriﬁed in the same
afﬁnity column. The purity of the proteins was checked by SDS-
PAGE andWestern blot. Total protein concentrationwas estimated
by the Bradford assay (Bio-Rad, Richmond, CA, USA). When
indicated, both variants of FH were puriﬁed exclusively by afﬁnity
column.
LEPTOSPIRA STRAINS AND CULTURE
Leptospira interrogans serovar Pomona strain Fromm, L. kirsh-
neri serovar Grippotyphosa strain Moskva V and L. borgpetersenii
serovar Javanica strain Veldrat Bataviae 46 were used in the assays.
All strains were obtained from the Laboratório de Zoonoses, Fac-
uldade de Medicina Veterinária e Zootecnia, University of São
Paulo, Brazil. Moskva V and Veldrat Bataviae 46 strains were
culture-attenuated by successive passages in artiﬁcialmedium.Vir-
ulence of the strain Fromm was maintained by iterative passages
in hamsters. Leptospires were cultured at 29˚C under aerobic con-
ditions in liquid EMJH medium (Difco® – USA) with 10% rabbit
serum, enriched with 0.015% (w/v) l-asparagine, 0.001% (w/v)
sodium pyruvate, 0.001% (w/v) calcium chloride, 0.001% (w/v)
magnesium chloride, 0.03% (w/v) peptone, and 0.02% (w/v) meat
extract.
IMMUNOELECTRON MICROSCOPY
The following protocol is modiﬁed after Barbosa et al., 2010.
L. interrogans serovar Pomona strain Fromm cells were washed
twice with PBS and ﬁxed with 2% paraformaldehyde in PBS for
60min at 22˚C. After two washes with PBS, bacteria were incu-
bated with 5μg/ml of puriﬁed FH (His402) or FH (Tyr402) for
60min at 22˚C with gentle agitation. After two washes with PBS to
removeunboundFH,bacteriawere applied to electronmicroscopy
grids and then incubated for 60min with a polyclonal goat anti-
human FH (Quidel) diluted 1:500 in PBS/1.5% BSA/0.05% Tween
20. After four washes with PBS/1% BSA, they were incubated
for 60min with rabbit anti-goat antibody–colloidal gold (10-nm
particles; Sigma-Aldrich, Co., St Louis, USA) and after succes-
sive washes in PBS/1% BSA, 0.85% NaCl, and bi-distilled water,
bacteria were stained with 2% uranyl acetate. Grids were exam-
ined with an electron microscope (Zeiss EM 109; Carl Zeiss, Inc.,
Oberkochen, Germany) at an accelerating voltage of 80 kV.
ASSESSMENT OF SURFACE ACQUISITION OF FH VARIANTS ON
LEPTOSPIRES BY ENZYME IMMUNOASSAY
Leptospires grown to mid-log phase were harvested by centrifuga-
tion at 5400 g for 30min and gently washed in PBS (pH 7.4) twice.
Bacteria were incubated with 0–20μg/ml of puriﬁed FH His402 or
FH Tyr402 for 60min at room temperature. After centrifugation
at 10000 g for 10min at 4˚C, the pellets were washed three times
with a buffer containing 1.0mM MgCl2, 0.6mM CaCl2, and 1%
glucose, and then suspended in 0.1M NaHCO3, pH 9.6. Bacte-
ria were used for coating ELISA plate wells overnight at 4˚C. The
wells were washed twice with PBS/0.05% Tween 20 (PBST) and
then blocked with 200 μl of 0.5% BSA for 2 h at 37˚C. Bound FH
was detected by adding 100μl of a 1:10000 dilution of goat anti-
human FH (Quidel) in PBS. Incubation proceeded for 60min at
37˚C and after three washes with PBST, 100 μl of a 1:10000 dilu-
tion of horseradish peroxidase-conjugated anti-rabbit IgG in PBS
was added to each well and incubated for 60min at 37˚C. The
wells were washed three times and o-phenylenediamine (0.04%)
in citrate phosphate buffer (pH 5.0) plus 0.01% H2O2. The reac-
tion was allowed to proceed for 10min and was then interrupted
by the addition of 50μl of 8M H2SO4. The absorbance at 492 nm
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was determined in a micro plate reader (Labsystems Uniscience,
Multiskan EX).
FH ADSORPTION ASSAYS USING INTACT LEPTOSPIRES
Freshly harvested leptospires (1× 109) were washed twice with
PBS (pH 7.4), and incubated with 5μg/ml of puriﬁed FH His402
or FH Tyr402 for 60min at 22˚C with gentle agitation. After ﬁve
washes with PBS (the last wash fraction was collected), proteins
bound to the surface of bacteria were eluted with 100μl of 0.1M
glycine–HCl pH 2.0 and supernatants were collected after cen-
trifugation. One ﬁfth (20μl) of the wash and eluate fractions was
subjected to 10% SDS-PAGE under non-reducing conditions and
transferred to nitrocellulose membranes. As a control, puriﬁed FH
(Calbiochem) was also loaded in the same gel. Non-speciﬁc bind-
ing sites were blocked using 10% (w/v) dried milk in PBS–Tween
(0.05%; pH 7.4) overnight at 4˚C. Subsequently, membranes were
rinsed three times in PBS–Tween (0.05%) and were incubated for
60min at room temperature with a polyclonal goat anti-human
FH (Quidel) at a 1:10000 dilution. Following three washes with
PBS–Tween (0.05%),membraneswere incubatedwith a secondary
peroxidase-conjugated anti-rabbit IgG Ab (Sigma) for 60min at
room temperature at a 1:10000 dilution. The positive signals were
detected by enhanced chemiluminescence (Super Signal, West
Pico, Pierce).
COFACTOR ACTIVITY OF LEPTOSPIRA-BOUND FH
The cofactor activity of surface-attached FH was assayed by mea-
suring Factor I-mediated cleavage of C3b (Grosskinsky et al.,
2009). One milliliter of freshly harvested leptospires (1 × 109)
were washed with a binding buffer (100mM NaCl, 50mM Tris–
HCl pH 7.4) and incubated with puriﬁed FH His402, FH Tyr402
(0.5–10μg/ml), or 10% NHS–EDTA (from blood samples geno-
typed homozygous for the FH His402 allele or the FH Tyr402 allele),
or binding buffer for 60min at room temperature with gentle
agitation. Bacteria were washed three times with washing buffer
(100mM NaCl, 50mM Tris–HCl, 0.05% Tween 20, pH 7.4), and
incubated with puriﬁed C3b (Calbiochem; 250 ng/assay) and Fac-
tor I (Calbiochem; 150 ng/reaction) for 60min at 37˚C. The sam-
ples were centrifuged and the supernatants were subjected to 10%
SDS-PAGE under reducing conditions and transferred to nitro-
cellulose membranes. Blocking treatment and incubations with
speciﬁc antibodies were performed as described above. Cleavage
products of C3b were detected using polyclonal goat anti-human
C3 (Calbiochem) at a 1:10000 dilution.
RESULTS
BINDING OF FH His402 AND FH Tyr402 TO LEPTOSPIRA SPP.
After incubation of L. interrogans Pomona strain Fromm with
puriﬁed human FH His402 or FH Tyr402, immunoelectron
microscopy was performed with anti-FH in order to evaluate
binding of both FH variants to this pathogenic strain. Colloidal
gold particles were detected on the leptospiral surface in both
cases. Representative electron micrographs are shown in Figure 1.
Apparently, no binding differences were observed at microscopical
level thus suggesting that both variants may interact equally with
FIGURE 1 | Immunoelectron microscopy analysis. L. interrogans
serovar Pomona strain Fromm was incubated with puriﬁed human
FH His402 (A,B) or FHTyr402 (C,D). After extensive washing,
leptospires were incubated with goat anti-human FH polyclonal
antibody followed by incubation with anti-goat IgG–colloidal gold
conjugated before analysis using an electron microscope (Zeiss
EM109). Both variants of FH were puriﬁed by gel ﬁltration and afﬁnity
chromatography.
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L. interrogans. Organisms incubated in PBS did not present surface
colloidal gold binding (data not shown).
To assess the interaction of human complement FH vari-
ants with Leptospira on a quantitative basis, we ﬁrst incubated
L. interrogans serovar Pomona strain Fromm with increasing
amounts of puriﬁed FH His420 or FH Tyr420 (over a range of
0.1–2μg/ml) and then immobilized the bacteria on microtiter
wells. Bound FH was detected with a speciﬁc antibody. FH Tyr402
binding to strain Fromm was signiﬁcantly stronger when com-
pared to FH His402 binding within the range of 0.1–2μg/ml
(Figure 2). Since FH is found in the serum at high levels, we
decided to extend this range up to 20μg/ml using three path-
ogenic leptospiral strains (Figure 3). At all FH concentrations
tested, FH Tyr402 binding to L. interrogans serovar Pomona strain
Fromm was signiﬁcantly stronger when compared to FH His402
binding to this virulent strain (P < 0.05; Figure 3). L. borg-
petersenii serovar Javanica strain Veldrat Bataviae 46 and L. kirsh-
neri serovarGrippotyphosa strainMoskvaV also bound FHTyr402
with an apparently higher afﬁnity at lower FH concentrations
(Figure 3).
Acquisition of FH variants by pathogenic leptospires was also
evaluated by Western blot. To this end, bacteria were incubated
with the same amount of FH His402 or FH Tyr402 and after exten-
sive washes the eluate fractions were separated by SDS-PAGE and
subjected to Western blot with anti-FH antibody. Interestingly,
FH His402 released by all three strains was more abundant when
compared to FH Tyr402 probably reﬂecting a higher afﬁnity of the
Tyr402 variant for the Leptospira surface (Figures 4A,B). In addi-
tion to binding FH, the Leptospira strains also bound members of
the FH-family, most probably FH-related protein 1 (FHR-1α and
FIGURE 2 | Dose-dependent binding of FH variants to L. interrogans
serovar Pomona strain Fromm. L. interrogans were incubated with
increasing amounts of puriﬁed FH His420 or FHTyr420 (0.1–2μg/ml) and then
immobilized on microtiter wells. The binding was assessed using a
polyclonal anti-human FH. Each point represents the mean absorbance
value at 492 nm± the SD of three independent experiments. *P ≤0.05
(Student’s two-tailed t -test). Both variants of FH were puriﬁed by gel
ﬁltration and afﬁnity chromatography.
FHR-1β; Figure 4A) as has been previously reported (Meri et al.,
2005).
LEPTOSPIRA-BOUND FH His402 OR FH Tyr402 DISPLAY SIMILAR
COFACTOR ACTIVITY
We next compared the regulatory role of FH His402 and FH Tyr402
attached to the surface of Leptospira, by analyzing degradation
of C3b mediated by Factor I. The serum-resistant L. interro-
gans serovar Pomona strain Fromm was incubated with puri-
ﬁed FH His402 and FH Tyr402 (0.5–10μg/ml), and also with
10% NHS (His402) or 10% NHS (FH Tyr402). After washing
FIGURE 3 | Dose-dependent binding of FH variants to Leptospira. L.
borgpetersenii, L. kirshneri, and L. interrogans were incubated with
increasing amounts of puriﬁed FH His420 or FHTyr420 (0–20μg/ml) and then
immobilized on microtiter wells. The binding was assessed using a
polyclonal anti-human FH. Each point represents the mean absorbance
value at 492 nm± the SD of three independent experiments. *P ≤0.05
(Student’s two-tailed t -test). Both variants of FH were puriﬁed only by
afﬁnity chromatography.
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FIGURE 4 | Acquisition of FH by L. borgpetersenii,L. kirshneri, andL.
interrogans. (A) Leptospires were incubated with puriﬁed FH His402, FH
Tyr402, or with buffer only. After extensive washing, surface–bound proteins
were eluted and subjected to non-reducing SDS-PAGE and analyzed by
Western blot using a polyclonal anti-human FH. (W) aliquots of the last
wash; (E) aliquots of the eluted fractions; puriﬁed FH (100 ng) was included
as a positive control. (B) Quantiﬁcation of the FH bands in part (A) as
described in Section “Materials and Methods.” Data are presented as
arbitrary units (AU). Both variants of FH were puriﬁed only by afﬁnity
chromatography.
to remove unbound FH, C3b, and Factor I were added. The
cleavage fragments of C3b in the supernatant were subjected
to Western blot with anti-C3 polyclonal antibody. The pres-
ence of a ∼46-kDa band indicates that acquired FH was able to
promote Factor I-mediated cleavage of C3b (Figure 5). In the
absence of FH,nodegradation fragmentswere detected (Figure 5).
Despite binding to Leptospira with different afﬁnities, both vari-
ants exhibited similar cofactor activities against C3b. This indi-
cates that they are equally efﬁcient in regulating the complement
cascade.
DISCUSSION
The AP of the complement system plays a pivotal role in the elim-
ination of invading microorganisms. In order to survive in the
host, pathogenic Leptospira have evolved mechanisms to avoid or,
at least,minimize lytic complement attack. Acquisition of the host
ﬂuid-phase complement regulators FH and C4BP is one strategy
adopted by these spirochetes to inhibit complement activation
(Meri et al., 2005; Barbosa et al., 2009). Binding of FH to Lep-
tospira spp. was ﬁrst assessed by Meri et al. (2005). Serum-resistant
and serum-intermediate strains were able to acquire FH and also
the FH-family protein member FH-related protein 1 (FHR-1).
Surface-bound FH remained functionally active as a cofactor for
Factor I in the cleavage of C3b (Meri et al., 2005). Leptospira’s
ability to bind either puriﬁed human FH or normal equine serum
FH has been examined by indirect immunoﬂuorescence analysis:
L. interrogans bound this complement regulator while the non-
pathogenic L. biﬂexa did not (Verma et al., 2006). Our immuno-
electron microscopy data presented in the present study provide
ultra-structural evidence consistent with these previous ﬁndings
and demonstrate that FH His402 and FH Tyr402 variants interact
with pathogenic Leptospira.
Recent results by our group indicate that Leptospira interact
with FH through two different binding sites, one located within
SCRs 5–7 and other located at theC-terminal SCRs 18–20 (unpub-
lished data). Considering that the His402 or Tyr402 polymorphism
of FH is located in SCR7, we decided to evaluate whether these
FH variants would display different binding afﬁnities for this
pathogen. According to the solid-phase binding assays, the FH
Tyr402 variant bound to the virulent strain Pomona more strongly
than the FH His402 did at all concentrations tested. Similar results
were observed for the two other pathogenic strains when they were
incubated with sub-saturating concentrations of FH. At higher
concentrations, no difference in binding was detected. We specu-
late that intrinsic properties of each strain might affect binding
to these FH variants. Since different binding afﬁnities for FH
His402 and FH Tyr402 may have functional consequences for the
pathogen with regard to susceptibility to complement-mediated
killing, we then compared cofactor activities of FH His402 and FH
Tyr402 bound to the surface of L. interrogans. Both variants were
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FIGURE 5 | Cofactor activity of FH variants bound to L. interrogans
serovar Pomona strain Fromm. C3b (100 ng) and Factor I (250 ng) were
added to bacteria that had been pre-incubated with FH His420, FHTyr420, or
with human serum. Reaction mixtures were separated by SDS-PAGE and
the cleavage fragments of C3b in the supernatant were subjected to
Western blot using a polyclonal anti-human C3. Lanes 1–9: reactions with
bacteria. C3b alone (1) or C3b mixed with 0.5μg of FH (2 and 5); 2.5μg of
FH (3 and 6); 10μg of FH (4 and 7); 100μl of serum from FH His420 subject
(8); 100μl of serum from FHTyr420 subject (9). Lanes 10–13: reactions
without Leptospira. Only C3b (10); C3b+FH (11); C3b+FI (12);
C3b+FH+Factor I (13). Both variants of FH were puriﬁed only by afﬁnity
chromatography.
functionally similar as cofactors for Factor I-mediated cleavage of
C3b. These results indicate that the two allotypes do not differ in
their capacity to regulate the complement cascade.
In a previous study,Yu et al. (2007) analyzed the interactions of
both FH variants withM6 protein from S. pyogenes, pneumococcal
surface protein C (PspC) from S. pneumoniae, and complement
regulator-acquiring surface protein 1 from Borrelia burgdorferi
(BbCRASP-1). While PspC and BbCRASP-1 bound equally well
to FH His402 and FH Tyr402, M6 protein interacted with the FH
Tyr402 variant with greater afﬁnity. Furthermore, reduced bind-
ing of the FH His402 variant of both FH and FHL-1 to GAS M6
protein has been observed by Ormsby et al. (2008). A compre-
hensive study by Haapasalo et al. (2008) involving almost 40 GAS
strains strengthened these ﬁndings, showing that the majority of
strains bound more weakly FH SCRs 5–7 allotype His402. More-
over, opsonophagocytosis was more pronounced when bacteria
were incubated in blood from individuals homozygous for the FH
(His402) allele (Haapasalo et al., 2008).
Factor H allotype His402 has been recognized as a leading risk
factor for the development of age-related macular degeneration
(Edwards et al., 2005; Haines et al., 2005; Klein et al., 2005). Nev-
ertheless, a number of studies report a high prevalence of the
homozygous genotype CC (that codes for His402) in different eth-
nic populations (Edwards et al., 2005; Haines et al., 2005; Klein
et al., 2005). A study analyzing populations from different conti-
nents found that the frequency of FH allele (His402) is between
0.15 and 0.25 (Haapasalo et al., 2008) and a recent study reported
a genotype frequency of 0.13 for CC (His402) in Brazilian indi-
viduals (Teixeira et al., 2010). This allele may confer a selective
advantage by, for instance, limiting evasion from the immune sys-
tem by pathogenic microorganisms or increasing susceptibility of
the pathogen to opsonophagocytosis (Yu et al., 2007; Haapasalo
et al., 2008; Ormsby et al., 2008).
Modeling studies of SCRs 6–7 of FH/FHL-1 predict that
the Tyr402His substitution will not cause a signiﬁcant structural
change in the molecule, but it does alter the electrostatic sur-
face charges (Ormsby et al., 2008). This may explain the reduced
binding of heparin to FHL-1 (Ormsby et al., 2008), C-reactive
protein, and GAS M6 protein to both FH and FHL-1 (Laine et al.,
2007; Yu et al., 2007; Haapasalo et al., 2008), and Leptospira to
FH (this study). We do not believe that the lower binding afﬁn-
ity of the FH His402 variant for Leptospira, in particular, could
have an important functional impact on bacterial survival in the
host tissues in which FH is relatively abundant (i.e., plasma). First,
because under physiological conditions, high FH levels are found
in the serum and, according to our data, differences in binding
between the two FH variants tend to disappear at higher FH con-
centrations. Secondly, both variants are functionally active and
display similar cofactor activities. However, these binding differ-
ences may be relevant at sites such as eyes where local FH synthesis
is low.
In conclusion, in this in vitro study we assessed the functional
consequences of the AMD-associated polymorphism FH His402
or FH Tyr402 on FH–Leptospira interactions. While our data sug-
gest that these variants have different binding afﬁnities to these
bacteria, both allotypes regulate the AP in a similar pattern; i.e.,
both act as cofactor of Factor I at similar efﬁciency. However,
we cannot rule out the possibility that other FH polymorphisms
may affect the interactions between this complement regulator
and Leptospira. In this work we did not address this possibility.
In addition, local tissue environment may directly inﬂuence the
regulatory role of FH in vivo in the eye. For example, the variant
FH His402 binds much less intensively to the Bruch’s membrane
in the macula region of retina than the Tyr402 variant; which may
be related to the etiopathogenesis of AMD (Clark et al., 2010). In
equines, L. interrogans is responsible for causing uveitis, a major
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cause of blindness in these animals (Verma et al., 2005). A con-
siderable fraction (18.4%) of infected patients from South India
developed uveitis after acute leptospirosis (Pappachan et al., 2007).
These considerations suggest that the role of FH polymorphism in
patients with leptospiral uveitis deserves further investigations.
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